关于Elekta |精密辐射医学|Elekta Hero

希望每个人都在处理癌症bob娱乐官网

在埃莱克塔(Elekta),我们有一个联合目的,激励我们作为一家公司和个人 - 希望每个人都在处理癌症。bob娱乐官网它驱使我们朝着我们的视野发展 - 每个人都可以获得最好的癌症护理。bob娱乐官网我们计划通过我们的使命到达那里 - 我们通过与客户和合作伙伴一起工作来改善患者的生活。

作为精密放射治疗解决方案的领先创新者,Elekta致力于确保每个患者都可以获得最佳的癌症护理。bob娱乐官网

Our offering allows clinicians to treat more patients with increased quality, both with value-creating innovations in solutions and AI-supported service based on a global network.

走向每个人都可以获得最好的癌症护理的世界bob娱乐官网

For almost half a century we've been working openly and proactively with clinicians and our partners to develop outcome-driven and cost-efficient solutions that meet evolving patient needs, no matter where they are in the world. To us it's personal and our global team of 4,700 employees combine passion, science and imagination to profoundly change cancer care, improve patient care and bring hope to everyone dealing with cancer.

“Today's shortage in radiotherapy equipment is unacceptable. We have a responsibility to change this and will do our part by delivering new, innovative solutions for cancer care."

Gustaf Salford,总裁兼首席执行官

古斯塔夫·索尔福德
about us graphic

我们改善癌症护理的策略bob娱乐官网

We want to do our part to move towards a world where everyone has access to the best cancer care. With our strategy ACCESS 2025 we set the focus on closing the access gap, elevating cancer care and increasing the patients' participation in their own care.

获得最佳癌症护理对Elekta意味着什么?bob娱乐官网

护理的可用性

在全球范围内改善物理进入放射疗法。通过在服务不足的市场中种植安装的基础(机器数量),我们希望确保全球人口中有更大的份额可以使用放射治疗。

2025 MILESTONE

+300M people
在服务不足的市场中,通过825个额外的Elekta Linac访问RT

护理升高

Improving patient access to better and more efficient care by driving clinical adoption of new technology, optimal utilization of available technology and improving clinical decision support.

2025 MILESTONE

2倍至4倍
double the clinical usage of short course treatment (hypofractionation) and quadruple the usage of adaptive treatments among Elekta customers

参与护理

通过获得更深入,更丰富的患者报告的见解,增加了患者参与自己的护理旅程,并增强了护理团队改善临床结果的能力。

2025 MILESTONE

+20%
Elekta客户的患者正在积极与自己的护理旅程互动(今天<1%)

  1. 谁报告癌症,可在bob娱乐官网https://www.who.int/publications/i/item/who-report-on-cancer-setting-priorities-investing-wisely-and-providing-care-for-all(除外,非黑色素瘤皮肤癌)。bob娱乐官网
  2. Ferlay J, et al. Global Cancer Observatory: Cancer Tomorrow. Lyon: International Agency for Research on Cancer, 2020; UN World Population Prospects 2019; International Atomic Energy Agency: DIRAC (Directory of Radiotherapy Centres), 2021
  3. Atun等人,扩大了全球接受放射疗法的访问,柳叶刀Oncol 2015 Sep;16(10):1153-86https://pubmed.ncbi.nlm.nih.gov/26419354/.